Actively Recruiting

Phase 2
Age: 18Years - 90Years
MALE
NCT06249750

Clinical Application of Near-infrared Whole Body Heat Shock Multimodal Technique in Treatment of Castration-resistant Prostate Cancer

Led by Pengyuan Liu · Updated on 2024-02-08

60

Participants Needed

1

Research Sites

156 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

In this study, we propose to use the combination of ET-SPACE NIR irradiation whole-body thermal stimulation, ICI (Tislelizumab), and RTK inhibitor (Anlotinib) in the multimodal treatment of CRPC.

CONDITIONS

Official Title

Clinical Application of Near-infrared Whole Body Heat Shock Multimodal Technique in Treatment of Castration-resistant Prostate Cancer

Who Can Participate

Age: 18Years - 90Years
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Histopathologically confirmed prostate cancer and clinically confirmed castration-resistant prostate cancer
  • Complete and reliable medical history and records
  • No other primary tumors except castration-resistant prostate cancer
  • Blood tests, liver function, kidney function, and electrocardiogram are basically normal
  • ECOG performance status score between 0 and 3
  • Age 18 years or older and younger than 90 years
  • Good compliance and able to accept regular follow-up
Not Eligible

You will not qualify if you...

  • History of malignant tumor other than prostate cancer within the past 5 years
  • Severe laboratory abnormalities that risk patient safety or study integrity
  • Severe underlying diseases that prevent tolerating therapy
  • Acute diseases such as infection or active bleeding
  • Recent participation in other clinical trials without completing washout period
  • Inability to tolerate systemic heat stress, e.g., claustrophobia
  • History of allergy to study drugs
  • Any other reasons determined by the study doctor that prevent enrollment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Zhejiang Hospital

Hangzhou, Zhejiang, China, 310013

Actively Recruiting

Loading map...

Research Team

P

Pengyuan Liu

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here